The Biotech Growth Trust PLC (BIOG.L)
GBp 679.31
(0.49%)
GBp 679.31
(0.49%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.24 Million | -5.89 Million | -12.14 Million | -5.67 Million | -3.76 Million | -4.39 Million |
| Net Income | 74.75 Million | -41.24 Million | -202.27 Million | 200.55 Million | 61.09 Million | 21.28 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 92 Thousand | -88 Thousand | -18.26 Million | 18.24 Million | -22 Thousand | -81 Thousand |
| Other non-cash items | 1.11 Million | 35.44 Million | 208.39 Million | -224.47 Million | -64.83 Million | -25.6 Million |
| Investing Cash Flow | 22.34 Million | 45.69 Million | 13.03 Million | -25.54 Million | 90.93 Million | 45.79 Million |
| Investments in PPE | - | - | -1.04 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -350.83 Million | -459.6 Million | -440.2 Million | -599.97 Million | -491.47 Million | -395.52 Million |
| Sales/Maturities of investments | 373.17 Million | 505.3 Million | 453.23 Million | 574.42 Million | 582.4 Million | 441.32 Million |
| Other Investing Activities | 22.34 Million | 45.69 Million | -1.04 Million | -25.54 Million | 90.93 Million | 45.79 Million |
| Financing Cash Flow | -18.74 Million | -37.03 Million | -2.39 Million | 32.72 Million | -87.16 Million | -41.4 Million |
| Debt repayment | -26.28 Million | -15.33 Million | -2.62 Million | -2.56 Million | -18.91 Million | -13.65 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -43.91 Million | -20.91 Million | -6.93 Million | - | -106.07 Million | -27.74 Million |
| Common Stock Issuance | - | - | 2.09 Million | 35.53 Million | - | - |
| Other Financing Activities | 25.17 Million | -16.12 Million | 2.44 Million | -2.81 Million | 18.91 Million | -13.65 Million |
| Accounts receivables | -6000.00 | 28 Thousand | -14 Thousand | 3000.00 | -17 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 98 Thousand | -116 Thousand | -18.25 Million | 18.23 Million | -5000.00 | -81 Thousand |
| Cash at beginning of period | 2.77 Million | - | 1.5 Million | - | - | - |
| Cash at end of period | 2.13 Million | 2.77 Million | - | 1.5 Million | - | - |
| Capital Expenditure | - | - | -1.04 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -641 Thousand | 2.77 Million | -1.5 Million | 1.5 Million | - | - |
| Free Cash Flow | -4.24 Million | -5.89 Million | -13.18 Million | -5.67 Million | -3.76 Million | -4.39 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 74.75 Million | 44.16 Million | 44.16 Million | -13.73 Million | -6.86 Million | -41.24 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 92 Thousand | -7500.00 | -7500.00 | -68 Thousand | 4500.00 | -88 Thousand |
| Other non-cash items | 1.11 Million | -45.34 Million | -45.34 Million | 11.39 Million | 5.92 Million | 35.44 Million |
| Investing Cash Flow | 22.34 Million | -6.84 Million | -6.84 Million | 36.03 Million | 18.01 Million | 45.69 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -350.83 Million | -234.63 Million | - | -116.19 Million | - | -459.6 Million |
| Sales/Maturities of investments | 373.17 Million | 220.93 Million | - | 152.23 Million | - | 505.3 Million |
| Other Investing Activities | 22.34 Million | -6.84 Million | -6.84 Million | 18.01 Million | 18.01 Million | 45.69 Million |
| Financing Cash Flow | -18.74 Million | 7.53 Million | 7.53 Million | -33.28 Million | -16.9 Million | -37.03 Million |
| Debt repayment | -26.28 Million | -35.9 Million | - | -9.61 Million | - | -15.33 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -43.91 Million | -10.12 Million | -10.12 Million | -23.66 Million | -11.83 Million | -20.91 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 25.17 Million | 17.65 Million | 17.65 Million | -5.06 Million | -5.06 Million | -16.12 Million |
| Accounts receivables | -6000.00 | -7500.00 | -7500.00 | 9000.00 | 4500.00 | 28 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 98 Thousand | 175 Thousand | - | -77 Thousand | - | -116 Thousand |
| Cash at beginning of period | 2.77 Million | 3.13 Million | - | 2.77 Million | - | - |
| Cash at end of period | 2.13 Million | 2.13 Million | -501 Thousand | 3.13 Million | 180.5 Thousand | 2.77 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -641 Thousand | -1 Million | -501 Thousand | 361 Thousand | 180.5 Thousand | 2.77 Million |
| Free Cash Flow | -4.24 Million | -1.18 Million | -1.18 Million | -2.39 Million | -936 Thousand | -5.89 Million |
EEGUF
MTO
INPST
5230
BBY
8432